About Our Home Page
Graphic and Herceptin The picture on JCCC's homepage shows a signaling
molecule (depicted as a greeny Pyramid) as it signals a normal cell to divide.
It is part of a series of graphics (below) showing how the breakthrough breast
cancer http://cancer.mednet.ucla.edu/images/herceptin.html
Nuclear Breast Imaging
Image directed breast biopsies Herceptine, New treatment modality TNM Breast
Cancer Staging HER 2/neu Survey HERCEPTIN: New Treatment Modality Author:
Julie Gralow, M.D. Dr. Julie Gralow is an assistant Professor at the
University of http://www.digitalclinic.com/herceptin.htm
Late Breaking News for
Health Care Professionals(in PDF format) Herceptin ® (Trastuzumab) as a single
agent is indicated for the treatment of patients with metastatic breast cancer
whose tumors overexpress the HER2 (human epidermal growth factor receptor2
http://www.gene.com/Medicines/herceptin.html
Welcome to herceptin.com
the only Web site dedicated to Herceptin® (Trastuzumab) and HER2 protein
overexpression. Provided are several key topics to enhance your understanding
of breast cancer and to familiarize you with Herceptin therapy. Also provided
http://www.her2.com/patient/index.html
Full Prescribing
Information BOXED WARNING DESCRIPTION OF HERCEPTIN® CLINICAL PHARMACOLOGY
CLINICAL STUDIES INDICATIONS AND USAGE CONTRAINDICATIONS WARNINGS PRECAUTIONS
ADVERSE REACTIONS OVERDOSAGE DOSAGE AND ADMINISTRATION HOW SUPPLIED REFERENCES
WARNING http://www.gene.com/Medicines/herceptin.pi.html
Herceptin is generally
well tolerated. The most common adverse events with Herceptin administration
include fever and chills, which are seen in 40 percent of patients. There is
an increased risk of cardiac dysfunction with Herceptin use, although severe
http://www.herceptin.com/prof/pp200a.html
Coming Soon: Information
for breast cancer patients The Herceptin Finding Your Way program provides
information and resources for breast cancer patients, in addition to answering
important questions about Herceptin. This initiative incorporates artwork
http://www.herceptin.com/prof/pn700.html
Now more than ever,
testing for HER2 protein overexpression plays a key role in the management of
breast cancer. With the availability of Herceptin® (Trastuzumab) for HER2
protein overexpressing metastatic breast cancer, patients who test positive
for this http://www.herceptin.com/prof/pp500.html
